Nursing Assignment
8 hours ago 5
NU553_Unit_2_Template.docx
NU553_Unit_2_Template.docx
NU553 Unit 2 Template
Review the grading rubric.
Antimicrobials and Antibiotic Stewardship
Student Name:
Date:
Instructor Name:
Introduction.
Legal/ Ethical and Regulatory Considerations.
Communication Civility
Cost- Effective Benefits.
Antimicrobial Stewardship.
|
Antimicrobial Agents |
||||||
|
Drug Class
Drug Name Brand/ Generic
|
Mechanism of action
|
Pharmacokinetics Key points |
Microbiology Key points |
Indications and Uses |
Dose via Age and Dose Considerations |
Warnings |
|
Penicillins
Penicillin G
(Penicillin G 2025) |
Beta-lactam antibiotic, interferes with bacteria cell wall synthesis ultimately leading to cell lysis
|
Protein bound to albumin in circulation
Crosses placenta and breast milk
Excreted in urine primarily |
Gram + Bacteria.Streptococcus pyogenes,S. pneumoniaeenterococcalSome gram-neg: meningeal cocci |
treponemal infections-syphilis meningococcal bacteremiaEndocarditis Botulism Pneumonia |
4-24 million units per day based on indication.
IV most often since poorly absorbed in the gut
Can be IM for short term indication |
Allergy
CHF related due to sodium content
Dose adjustment for renal impairment
|
|
Beta-Lactam/ Beta Lactamase Inhibitor |
|
|
|
|
|
|
|
1st Generation Cephalosporin |
|
|
|
|
|
|
|
Fluoroquinolone |
|
|
|
|
|
|
|
Macrolide |
|
|
|
|
|
|
|
Aminoglycoside |
|
|
|
|
|
|
|
Tetracycline |
|
|
|
|
|
|
|
Sulfonamide
|
|
|
|
|
|
|
|
Fusion Inhibitor
|
|
|
|
|
|
|
|
Nucleoside Analogs |
|
|
|
|
|
|
|
Protease Inhibitor |
|
|
|
|
|
|
References
Penicillin G. (2025). Merck Manual https://www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-medications/penicillins?query=pen%20vk#Pharmacokinetics_v13957234
NU553_Unit_2_Template.docx
NU553 Unit 2 Template
Review the grading rubric.
Antimicrobials and Antibiotic Stewardship
Student Name:
Date:
Instructor Name:
Introduction.
Legal/ Ethical and Regulatory Considerations.
Communication Civility
Cost- Effective Benefits.
Antimicrobial Stewardship.
|
Antimicrobial Agents |
||||||
|
Drug Class
Drug Name Brand/ Generic
|
Mechanism of action
|
Pharmacokinetics Key points |
Microbiology Key points |
Indications and Uses |
Dose via Age and Dose Considerations |
Warnings |
|
Penicillins
Penicillin G
(Penicillin G 2025) |
Beta-lactam antibiotic, interferes with bacteria cell wall synthesis ultimately leading to cell lysis
|
Protein bound to albumin in circulation
Crosses placenta and breast milk
Excreted in urine primarily |
Gram + Bacteria.Streptococcus pyogenes,S. pneumoniaeenterococcalSome gram-neg: meningeal cocci |
treponemal infections-syphilis meningococcal bacteremiaEndocarditis Botulism Pneumonia |
4-24 million units per day based on indication.
IV most often since poorly absorbed in the gut
Can be IM for short term indication |
Allergy
CHF related due to sodium content
Dose adjustment for renal impairment
|
|
Beta-Lactam/ Beta Lactamase Inhibitor |
|
|
|
|
|
|
|
1st Generation Cephalosporin |
|
|
|
|
|
|
|
Fluoroquinolone |
|
|
|
|
|
|
|
Macrolide |
|
|
|
|
|
|
|
Aminoglycoside |
|
|
|
|
|
|
|
Tetracycline |
|
|
|
|
|
|
|
Sulfonamide
|
|
|
|
|
|
|
|
Fusion Inhibitor
|
|
|
|
|
|
|
|
Nucleoside Analogs |
|
|
|
|
|
|
|
Protease Inhibitor |
|
|
|
|
|
|
References
Penicillin G. (2025). Merck Manual https://www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-medications/penicillins?query=pen%20vk#Pharmacokinetics_v13957234